Indeed, increased rates of serious bacterial infections are well described in patients receiving anti-TNFα therapies53, and our findings suggest that a state of relative immunosuppression mediated by corticosteroid treatment may augment susceptibility to opportunistic bacterial pathogens in COVID-19 patients. The gene discussed is TNF; the disease is COVID-19.